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Abstract 
A causal link between the increasing environmental pollution and the fast spreading of allergic diseases is 
currently discussed.  
The exogenic and endogenic noxious agents contributing to the total environmental load are primarily acting 
through immunotoxic, sensitizing and neurotoxic mechanisms in animal experiments and in humans. Beside classic 
allergic-triggering  factors  (allergen  potency,  intermittent  exposure  to  different  allergen  concentrations,  presence  of 
microbial bodies and sensitizing phenols), the adjuvant role of environmental pollutants gains increasing importance in 
allergy induction.  
Our therapy experience with more than 18.000 atopic eczema patients shows that beside allergic reactions 
pseudoallergic  mechanisms  through  toxic  environmental  agents  (formaldehyde,  industrial  and  traffic  smog,  wood 
preservatives, microbial toxins, additive-rich food, nicotine, alcohol, pesticides, solvents, amalgam-heavy metals) are 
increasingly incriminated as causal factors for the complex symptomatology. 
The avoidance and elimination of such triggering factors before and during pregnancy and in early childhood 
may result in a significant decrease of the incidence of atopic diseases.  
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Recent statistics of the Federal Republic 
of Germany report more than 25 million cases of 
allergies; nearly every week mass media report a 
new environmental problem, so that a relationship 
between  environmental  load  and  break-out  of 
allergies becomes more and more apparent. 
This development was nearly unknown until the 
2nd half of the 20th century, but just in the last 
20-30  years,  parallel  to  the  increasing 
environmental  pollution,  a  rapid  spreading  of 
allergies was noticed, especially in major cities. 
 
Pollutants responsible for total environmental 
load 
We may actually count more than 7×106 
chemical compounds with a yearly increasing rate 
of more than 250 000 new substances. More than 
50,000  are  used  daily.  They  contribute  to  the 
environmental  load  of  the  air  by  exhaust  fumes 
(SO2, NO2, CO) of cars, industrial factories and 
power stations, industrial dust, excess of ozone as 
well as the chemical burden of soil and water with 
pesticides,  fertilizers,  insecticides,  heavy  metals 
and chemical or radioactive residues. Virtually no 
one  can  avoid  over  longer  time  the  negative 
effects  of  different  toxins  like  asbestos, 
formaldehyde,  wood  preservatives,  adhesives, 
oils,  petrol  and  solvents,  resins,  detergents  and 
heavy  metals.  Besides,  daily  intake  of fast  food 
products may cause various side effects through 
preservatives,  dye-stuffs,  binding  substances, 
gelatines, emulsifiers and taste intensifiers giving 
our food a long stability, an appetizing appearance 
and the desired taste. Cosmetic ingredients, drugs 
and  pharmaceutical  products  as  well  as  dying-
stuff and synthetic materials of the textile industry 
are also potential triggers of intolerance reactions. 
Furthermore,  allergic  and  chemical 
sensitive patients frequently react upon exposure 
to  electromagnetic  fields  of  different  electrical 
equipments like PC's, TV, HiFi- and other house 
devices,  antennas  and power lines  as well as to 
radioactive  residues  from  environmental  and 
medical sources. The burden of the daily psycho-
social stress (distress) added to the above factors, 
makes a first sum-up of the body’s load through 
exogenous environmental challenge. 
The  function  of  different  body  systems 
can  also  be  impaired  when  chronic  infections 
through  bacteria  and  yeasts  are  colonizing  the 
mucosa of the respiratory, urinary and intestinal 
tract.  Their  metabolic  and  catabolic  products 
(endo-,  exo-  and  mycotoxins,  indol,  scatol, 
phenol,  biogenic  amines  etc.)  together  with  the Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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mobilization of toxic heavy metals from pessars, 
amalgam  fillings,  dental  crowns  and  other 
prostheses,  ionogens  of  different  implantations 
(synthetic  material,  silicon,  acrylate,  dental 
cement)  are  making  a  second  group  of 
endogenous factors  also contributing to a toxic 
cumulative raise of the oxidative stress. American 
authors introduced some years ago the term "Total 
Environmental  Load"  as  standard  for the  body's 
total burden through pollutants [1]. 
The  contact  with  the  described  noxious 
agents happens primarily in the respiratory system 
through  inhalated  stuff,  in  the  intestinal  tract 
through food and water as well as through the skin 
and causes different effects. Via skin and mucosa 
most  toxins  disturb the  metabolic  processes  and 
cellular structures of the immune system and / or 
of  the  central  nervous  system.  As  a  direct 
consequence, immunotoxic or mitogenic effects  
 
of  the  blood  cell  subpopulations  [2,3]  are 
observed as well as the decrease of the secretory 
immune globulins [4,5], normally connected with 
an  increased  susceptibility  for  infections  of  the 
skin,  mucosa  and  intestine,  as  often  found  in 
allergic patients [6]. 
The  various  neurotoxic  effects  of 
pollutants  can  break  out  as  headache,  dizziness, 
concentration  problems,  tremble,  insomnia  and 
disturbances  of  the  cardiac  rhythm  up  to 
depressions  and  partial  paralysis  [7-10].  A 
disturbed  release  of  catecholamines  in  chemical 
sensitive  hyperkinetic  (dopamine)  and  atopic 
(noradrenalin) patients was also reported [11, 12]. 
A  part  of  the  pollutants  is  stored  in  fat  tissue, 
bones and nervous system and will occasionally 
be  mobilized  with  negative  effects  for  the 
patients. This was clearly documented by analytic 
investigations of the fat tissue (Table 1). 
  Year  Number 
of tests 
Average levels (mg/kg) of 
 
      p,p'- DDE  pp-DDT  Dieldein  HCB  total 
HCH 
PCB 
Belgium  1975  60  6.5  1.52  0.26  1.36  0.76*  0.91 
Kanada  1972  168  2.095  0.439  0.069  0.06  0.065  0.91 
Germany 
(West) 
  282  4.4  1.1  0.14  5.6  0.99  8.3 
Greece    50  7.86  1.99  0.23  3.84  0.98**   
Japan  1974  30  2.91  0.68      2.36  1.04 
Northern 
Ireland 
1975  11  1.60  0.34  0.10  0.15  0.45   
Spain  1977  40  2.268  1.781  0.150    0.062   
Switzerland  1971/72  12  3.8  1.6  0.29  1.9  0.90  1.0 
England  1976/77  236  5.1  0.21  0.11  0.19  0.33  0.7 
USA  1973/74  898  2.1    0.15    0.21*   
New Zealand  1973  51  4.4  0.46  0.21  0.31  0.49  0.82 
Danmark  1972/73  78  3.7  0.6  0.12      3.8 
                 
* Measured as ß-HCH;   ** measured as Lindan 
 
 
 
As  such  cases  occurred  more  and  more 
frequently,  new  medical  notions  like  "Multiple 
Chemical  Sensitivity"  and  "Sick  Building 
Syndrome"  associated  with  complex  systemic 
symptoms  were  introduced  in  the  last  years.  A 
part of the patients believes to have an allergy to 
environmental chemicals although this allergy is 
not evident by classic immunological tests. On the 
other  side,  allergists  have  noticed  that  most  of 
their patients with asthma, atopic eczema, allergic 
rhinitis  or  urticaria  are  simultaneously 
environmental  reactions  showing  an  increased 
sensitivity to smallest concentrations of different 
pollutants  and  biogenic  toxins.  Their  symptoms 
Table 1: Levels of different organo chlorinated compounds in human fatty tissue [80] 
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are mostly due to a mixture of allergic and pseudo 
allergic  reactions.  Experts  already  talk  about 
allergotoxicology as a new interdisciplinary field 
including allergic and chemo-sensitive patients. 
 
Triggering factors of allergic reactions 
A complex relationship between different 
blood  cells  like  macrophages,  lymphocytes, 
eosinophiles,  basophiles,  monocytes  and 
granulocytes,  mediated  by  specific  cytokines  is 
known  to  play  an  important  role  in  inducing  a 
normal  immune  response  or  an  allergic  reaction 
with inflammatory components, respectively. 
According to Gell and Coombs immediate 
and delayed allergic reactions of Type I to Type 
IV can happen, always with participation of the 
immune system. Besides a hereditary disposition 
for atopy being most intense if both parents are 
atopics (prevalence of the atopy of 60-80% in the 
filial generation), several trigger factors may play 
an important role for the induction of an allergy. 
To these belong: 
1.  Allergen potency and exposure. An early 
stop  of  the  breast  feeding  and  the 
replacement with food formula based on 
strong  allergens  like  cow  milk,  soy  or 
food  with  parts  of  eggs  and  yeast  are 
known as factors for an allergy induction 
in babies [13]. The chemical combination 
of the so-called haptens is hereby crucial 
for the allergen potency and the repeated 
intermittent  exposition  to  different 
allergen  concentrations  is  also  a  known 
prerequisite for the induction of allergy. 
2.  Microbial  bodies  like  Mycobacterium 
tuberculosis  or  Bordetella  pertussis  [14] 
and  different  irritating  substances  like 
phenols  (Freund’s  adjuvant)  can  also 
mediate the induction of an IgE-response 
and  allergy  in  animal  experiments.  A 
similar  situation  may  happen  in  babies 
being  early  infected  by  facultative  or 
obligate pathogen  germs of the mother’s 
birth tract or in the hospital, leading to an 
early contamination of the intestine with 
an  abnormal  flora.  Similar  microbial 
conditions  combined  with  production  of 
large  amounts  of  sensitizing 
decomposition  products  (e.g.  biogenic 
amines, phenols) can also arise later from 
antibiotic  treatments  damaging  the 
intestinal flora or under the influence of 
radiation, cytostatic or cortisone therapies, 
all with immunosuppressive effects. 
Such dysbiotic conditions of the intestine are 
markers  of  allergic  diseases  [15].  They 
are  reversing  the  normal  priming  of 
immunocompetent lymphocytes in the gut 
associated  lymphoid  tissue  (GALT) 
towards increased numbers of Th2 cells, 
IL-4 generation and IgE-synthesis [62,63]. 
3.  Different pollutants have an adjuvant role 
for  the  induction  of  allergies.  Several 
mechanisms are possible: 
  Damage of the skin and mucosal barriers 
through  chemical,  physical  or  microbial 
influences  via  direct  injury  of  cell 
membranes  and  release  of  inflammatory 
agents like histamine, prostaglandins and 
leucotrienes,  especially  after  pesticide 
exposure  [16,17],  alcohol  and  microbial 
toxins.  The  raised  permeability  of  the 
mucosal  barriers  leads  to  an  increased 
intake  of  allergens  followed  by 
sensitization [18]. 
  A raised IgE-production and outbreak of 
allergic  symptoms  after  diesel  exhaust 
particles  [19],  tobacco  smoke  [20,21], 
mercury  compounds  [22]  and  platinum 
salts  [23]  was  also  reported.  The 
increased toxin concentrations can spread 
their  effects  on  different  cellular  levels, 
depending  on  their  absorption  and 
irritation potential. 
  Induction of the IgE-synthesis after toxin 
(e.g.  formaldehyde)  binding  on  serum 
proteins  [24]  with  formation  of  new 
antigen structures. 
  Conformational  changes  of  the  cellular 
surface  after  contact  with  heavy  metals 
combined  with  sensitizing  effects  for 
antigen  specific  T-lymphocytes  and 
leading  to  their  proliferation  and 
differentiation (contact allergies) [25,26]. 
  Intervention  in  the  intermediary 
metabolism  by  influencing  the  structure 
and  biological  activity  of  different 
enzymatic  systems,  RNA,  DNA  and 
protein syntheses (methyl Hg inactivation 
of  SH-proteins,  DNase,  ATPase  and 
oxidative  phosphorylation,  alcohol  and 
nicotine  inhibition  of  MAO/DAO 
activities etc.) [27-31]. 
As  a  rule,  symptoms  of  allergic  and/or 
chemical sensitive patients are the consequence of 
interactions  between  their immune/detoxification 
systems and the influences of inappropriate food, 
exogenic pollutants and endogenous toxins. 
This  explains  the  polymorbid  clinical 
status  of  such  patients.  The  importance  of 
preventive medical steps is evident - by avoiding 
relevant  allergens  and  pollutants  –  and  of  an 
appropriate healthy life-style in the psychosocial 
respect as well. Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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Allergotoxic factors in atopic eczema (AE) 
Our experience in the treatment of more 
than 18,000 atopic eczema, urticaria and contact 
dermatitis patients shows, that besides the allergic 
mechanisms  more  and  more  pseudo  allergic 
reactions  caused  by  toxic-irritative  pollutants 
(formaldehyde,  exhaust  particles,  additive-rich 
food,  nicotine,  wood  preservatives,  pesticides, 
heavy  metals)  are  responsible  for  the  complex 
symptoms.  Intrauterine  and  postnatal  influences 
of such factors were also reported [32,33]. 
Highly interesting in atopic eczema (AE) patients 
is  the  occurrence  of  allergic  and  pseudoallergic 
reactions  against  food  and  food  additives, 
investigated in controlled studies before and after 
challenge meals [18]. Besides a distinct increase 
in  the  serum  levels  of  circulating  immune 
complexes and specific IgE and IgG4 antibodies 
against  food,  the  investigation  of  the  serum 
histamine  levels  before  and  1/2  hour  after 
challenge  meals  shows  in  AE  patients  a  highly 
significant increase of the mediator after the food 
intake [Fig. 1]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, as the fasted serum of AE patients also 
contains high histamine levels, we investigated  
 
the catabolism of this biogenic amine. 
Diaminoxidase  (DAO)  is  the  main  splitting 
enzyme for histamine, but also monoaminoxidase 
(MAO) plays a role in its catabolic pathway. In a 
study  about  the  MAO-  and  DAO-activity  in 
thrombocyte-rich  plasma  of  AE  patients  and 
healthy controls we were able to demonstrate that 
the  activities  of  MAO  and  DAO  were 
significantly  decreased  in  AE  patients  when 
compared to controls. Simultaneously we noticed 
significantly  increased  histamine  levels  in  the 
same  fasted  AE  patients  (Table  2)  [64].  High 
concentrations of biogenic amines, e.g. putrescine, 
octopamine  and  histamine,  are  known  inhibitors 
of these catabolic enzymes. 
Further  inhibitory  factors  are  food 
additives,  heavy  metals,  alcohol  and  nicotine, 
whereby alcohol additionally leads to an increased 
absorption of biogenic amines from the intestinal 
tract.  Some  drugs,  for  example  certain 
antidepressants, act as MAO blocker as well. On 
the other side, the cofactors for MAO (iron and 
FAD) are decreased in AE patients, the cofactors 
for  DAO  (copper  and  pyridoxalphosphate)  are 
nearly normal, suggesting excesses of the enzyme 
inhibitors mentioned above [31]. 
These findings explain the pseudoallergic, 
non-immunological  mediated  reactions  against 
certain foods like frozen fish containing 10 times 
higher  histamine  levels  than  fresh  fish.  In 
different  varieties  of  blue  cheese,  sour  cabbage, 
pickled cucumbers or ketchup high concentrations 
of  histamine  can  be  found,  too.  Pseudoallergic 
reactions  against  other  biogenic  amines  like 
tyramine,  octopamine,  phenyl  ethylamine  or 
putrescine  may  also  happen  because  splitting 
enzymes  like  MAO  and  DAO  are  inhibited  or 
lacking. High concentrations of the biogenic amin 
tyramin are found for instance in sausages, beer, 
red  wine,  champagne  and  certain  varieties  of 
cheese.
 
Type B monoamine oxidase 
(mmol min 
-1 l 
-1) 
 
Diamine oxidase 
(mmol min 
-1 l 
-1) 
Histamine 
(ng ml 
-1) 
Atopic eczema patients  0.223 ± 0.11 
(n = 19) 
0.270 ± 0.089 
(n = 18) 
6.63 ± 1.64 
(n = 19) 
Controls  0.371 ± 0.085 
(n = 11) 
0.511 ± 0.125 
(n = 10) 
2.15 ± 0.96 
(n = 10) 
Significance Student t test  P < 0.05 
  P < 0.001  P < 0.0001 
 
 
 
Fig.1 Serum histamine levels in atopic eczema 
patients 
Before and ½ hr after challenge meal 
Table 2  Monoamine and diamine oxidase activities in platelet-rich plasma 
of atopic eczema patients and healthy controls 
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The  increased  intestinal  permeability  in 
atopic  patients  enables  a  significantly  raised 
antigen absorption which in turn leads to higher 
levels  of  circulating  immune  complexes, 
activation of the complement system and of the 
coagulation  cascade  and  to  the  IgE  mediated 
degranulation of the granulocytes and basophiles 
[18].  However,  a  direct  correlation  between  the 
increased intestinal permeability on the one side 
and the serum histamine levels or the presence of 
IgE-containing  CIC's  on  the  other  side  was  not 
found. 
The  reason  for  the  increased  intestinal 
permeability  [Fig.  2]  lies  in  the  significant 
intestinal dysbiosis of most AE patients depicting 
an  excess  of  facultative  pathogenic  bacteria  or 
yeasts and a decrease of the beneficial, lactic acid 
producing flora, respectively [15]. 
In a previous study with 110 AE patients we 
found that in nearly 85% of the investigated cases exist 
the dramatically lowered levels of lactobacilli and bifid 
bacteria  was  paralleled  by  a  strong  increase  of 
facultative pathogenic germs like haemolytic E. coli, 
Klebsiella sp., Proteus sp., Clostridium sp. and fungi 
like Candida or Geotrichum sp. (Table 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lactobacilli 
 
Bifidobacteria 
 
haemolyt. 
coliforms 
 
Klebsiella 
 
Proteus 
 
pathogenic 
Clostridia 
 
Candida / 
Geotrichum 
 
Normal 
range 
(germs / 
g moist 
stool) 
> 10
6  > 10
8  < 10
4  < 10
4  < 10
4  < 10
5  < 10
3 
AE-
patients 
 
n = 110 
(p%) 
 
absent or 
< 10
4 
76 (69%) 
< 10
7 
31 (28.2 %) 
> 10
6 
52 (47.3%) 
> 10
6 
36 (32.7 
%) 
> 10
5 
22 (20%) 
> 10
6 
40 (36.3%) 
10
4-10
7 
48 (43.6%) 
controls 
 
n = 30 
(p%) 
 
2 x 10
4 
3 (10%) 
> 10
8 
30 (100%) 
3 x 10
5 
2 (6.6%) 
< 10
4 
30 (100%) 
< 10
4 
30 
(100%) 
< 10
5 
30 (100%) 
2.5 x 10
4 
3 (10 %) 
 
 
 
A  lactose  malabsorption  test  performed 
during the same study demonstrated significantly 
reduced levels of galactose in blood and urine of 
the  AE  patients,  when  compared  to  healthy 
controls. It is well known that the existing lactose 
malabsorption originates in a deficiency of lactase 
activity.  The  frequent  intolerance  reactions 
against sugar and sugar products in atopic patients 
are  pseudoallergic  reactions  caused  by  a 
secondary  disaccharides  deficiency  inducing 
diarrhoea, intestinal colics, migraine, skin rushes 
and oedema. The non-digested sugars in the gut 
support  a  strong  increase  of  pathogenic  bacteria 
and  above  all  of  fungi.  Candida  albicans  and 
haemolytic E. coli are the main inhibitors of the 
lactase activity [34,35]. 
By fermentation, different intestinal yeast 
and  bacterial  strains  transform  the  ingested 
Fig.2  Intestinal permeability in atopic eczema 
patients, measured by procentual determination of 
the Urinal PEG 4000 S after 24 hrs  
Table 3  Intestinal microflora of 110 atopic eczema patients and 30 healthy controls 
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carbohydrates in organic alcohols [36] and short 
chain  fatty  acids  with  narcotic  effects  [37,  38] 
explaining  the  significant  postprandial  tiredness 
and alcohol intolerance of the patients, as well as 
their  increased  intestinal  permeability.  Most 
Candida  strains  generate  phospholipase  A2, 
whereby membrane phospholipids can be splited 
to  archidonic  acid  and  then  oxidized  to 
prostaglandins and leucotrienes with an important 
inflammatory  potential.  Toxic  decomposition 
products of meat (indol, scatol, phenols, biogenic 
amines)  produced  by  a  putrefactive  flora 
(Clostridium,  Bacteroides  sp.,  pathogenic 
Enterobacteriaceae)  are  also  increasing  the 
irritability of the skin, mucosa and nervous system 
and act as adjuvant factors (e.g. phenols) for the 
induction  of  the  IgE  synthesis  (Freund’s 
adjuvant). 
Therefore  the  identification  and 
elimination of chronic microbial foci of the skin, 
lungs and especially of the gut is essential for a 
successful therapy in atopic patients.  
 
Disturbed  energy  metabolism  and 
regulation factors 
 
Further  side-effects  of  a  disturbed 
intestinal  flora  were  discussed  in  detail  in  a 
former  study  [15].  The  reduced  absorption  of 
carbohydrates  caused  by  inhibition  of 
dissacharidases together with a disturbance of the 
intermediary metabolism by environmental toxins 
of  different  kind  (PCP,  pesticides,  industrial 
smog,  heavy  metals,  polychlorinated  biphenyls, 
microbial poisons etc.) produces a more and more 
reduced  formation  of  energy-rich  substances 
(ATP)  in  AE  patients  shown  in  several 
investigations [Ionescu G, Benkert P, 1988]. This 
is one of the main important causes for low levels 
of  cyclic  nucleotides  (cAMP)  with  regulation/ 
control  function  when  releasing  inhibition 
mediators.  The  cAMP-levels  are  additionally 
reduced  by  simultaneous  blockage  of  beta-
adrenoreceptors  [39,40]  and  by  the  increased 
activity  of  the  camp  splitting  enzyme 
phosphodiesterase [41]. 
 
Heavy metal burden in atopic patients 
 
In  the  last  years  it  was  more  and  more 
reported  about  the  immune-  and  allergotoxic 
relevance of heavy metal burden (cadmium, lead, 
platinum, copper) [2,42-45]. 
Mercury  plays  a  specific  role,  even 
because  of  the  intensive  discussion  about 
"amalgam". It is important to divide between the 
allergic potential of mercury (up to 17% allergy 
incidence with positive epicutan testing’s) and his 
chronic-toxic  potential  leading  especially  in 
allergic  patients  to  an  accelerated  summation 
effect with other pollutants. \ 
Some examples of several mechanisms for the 
attack are referred: 
–  Binding  to  serum  and  cell  proteins 
(albumin, coenzyme A, SH-proteins) with 
interactions  in  the  intermediary 
metabolism [27]. 
–  Rise  of  the  cellular  mitosis  rate  in 
lymphocytic populations [46]. 
–  Induction  of  the  IgE-synthesis  with 
increase  of  the  allergen  specific  IgE-
answer in rats [22]. 
–  Decrease  of  total  T-lymphocytes,  T-
helper  cells  and  natural  killer  cells  after 
mercury  release  from  amalgam  fillings 
[47,48]. 
–  Stimulation of inflammatory reactions by 
activation of the corresponding enzymatic 
systems (for example collagenases [49]). 
–  Exceptionally important for patients is the 
transformation  of  the  ionisized  Hg2+-
form through methylation in a more toxic, 
lipid  soluble  organic  compound  (methyl 
mercury) [27]. Oral and intestinal bacteria 
(streptococci,  clostridia)  [50]  and 
especially yeasts (Candida albicans) [51] 
accomplish this process and partly explain 
the  tolerance  differences  between 
amalgam carriers. 
Although  the  clinical  relevance  of  these 
results  for  the  pathogenesis  of  atopic  eczema  is 
still  controversial,  the  most  important  mercury 
sources  remain  always  the  same:  as  addition  in 
different  drugs  (liniments,  drops,  and  vaccines), 
fish-rich  food,  entrails  (0.3-2.3µg/day)  and 
especially  amalgam  fillings  (3-17µg  mercury 
vapour/day [27]). 
Mercury possesses an evident affinity for the 
epithelial cells of the gastrointestinal tract  and the 
skin,  for  hair,  thyroid  gland,  liver,  pancreas, 
kidneys  and  the  brain  (above  all  the  grey 
substance as well as in central areas of the brain 
stem  and  the  cerebral  cortex)  [52-54].  Spin-
tomographical investigations of the head are not 
practicable, if patients carry dental alloys in the 
stoma [55]. 
Our  own  investigations  in  atopic  eczema, 
urticaria and psoriasis patients show by means of 
the  so-called  "chewing-gum  test"  a  considerable 
metal release, directly correlating to the number 
of  fillings  [56].  This  phenomenon  is  not  only 
significant for the patients, but also for pregnant Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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women  and  mothers,  then  according  to  newer 
findings  the  release  of  mercury  leads  to  a 
transplacental burden of the foetal tissues [32,33] 
as well as of the babies by mother's milk [57]. The 
release  from  the  fillings  is  more  severe  after 
intake of hot drinks (coffee, tea), fruit juices, and 
fresh  fruits  or  during  gum  chewing.  The 
allergotoxic effect of mercury is often multiplied 
through  synergistic  effects  of  other  pollutants 
(pesticides, dioxins, furans etc.) from breast-milk. 
According to our experience with over 18,000 
allergic skin patients two facts are certain: 
a) Dentists drill work in the amalgam fillings 
of  allergic  patients  without  appropriate 
protection (cofferdam, antioxidants) generally 
lead  to  a  rapid  worsening  of the  symptoms, 
and 
b) Therapy resistant, recurrent atopic eczema 
of  the  head,  neck  and  face  skin  as  well  as 
chronic  rhinitis  and  pharyngitis  greatly 
improve  or  subsides  after  the  removal  of 
amalgam  fillings  followed  by  adequate 
mobilisation procedures [58]. 
 
Prophylaxis and therapy 
 
Important  preventive  steps  for  allergic 
patients may already be accomplished in pregnant 
women,  whereby  the  avoidance  of  strong 
allergens in food, alcohol, nicotine and exogenic 
toxins can lead to a decrease of the baby's atopic 
risk  [13].  Also  the  clearing  of  endogenic  load 
factors like chronic infections of the skin, mucosa, 
birth tract and intestine find its justified use. 
An allergen-poor diet offered in a rotation 
system,  together  with  the  clearing  of  microbial 
foci,  toxin  mobilisations,  immunmodulation  and 
psychological care are important promoters of a 
long-term recovery [59,60]. 
Main  therapy  steps  in  atopic  patients  may 
therefore include:  
  Immediate  compensation  of  the  redox 
and free radical status of the blood. 
  Elimination of pathogenic germs of the 
skin,  mucosa,  respiratory  system, 
urinary tract and intestine. 
  Restoration of a healthy intestinal flora 
and function, by means of antimycotics, 
plant  extracts,  appropriate  food  and 
lactic acid producing bacteria. 
  Reduction  of  increased  levels  of 
pathogenic  substances  in  blood  as 
biogenic  amines,  endotoxines, 
pathogenic  antibodies  and  circulating 
immune complexes. 
  Specific or unspecific modulation of the 
humoral and cellular immune function 
by  intake  of  immunoglobulines, 
selected  thymus  extracts  and  other 
biological agents. 
  Modulation  of  neurohormonal 
imbalance  (noradrenalin,  dopamine, 
serotonin). 
  Activation of the detox systems of the 
liver  and  blood  (alcohol/aldehyde 
dehydrogenase,  phenoloxidase, 
monoaminoxidase,  methyltransferase, 
GST). 
  Compensation  of  deficits  of  vitamins, 
minerals,  trace  elements,  amino  acids, 
enzymes,  essential  fatty  acids  and 
energetic  substances  by  appropriate 
substitution therapy. 
  Preparation  of  appropriate  diet  plans 
considering the individual allergic  and 
pseudoallergic intolerance reactions. 
  Dietary  treatment:  Based  on  the 
individual  spectrum  of  food 
intolerances, there is no ideal diet plan 
for  all  atopic  patients.  An  extensive 
panel  of  diagnostic  procedures  for 
allergic  and  pseudoallergic  reactions 
against  food  antigens  and  additives  is 
therefore imperative before completing 
a diet plan. These include detection of 
food allergens by means of specific IgE 
and IgG4 antibodies, histamine and free 
radical  release  before  and  after 
challenge  with  foods  or  additives, 
identification  of  lactose,  fructose  or 
sucrose  intolerances  as  well  as 
pseudoallergic reactions resulting from 
microbial  fermentation/putrefaction 
processes in the gut. 
 
Conclusions 
 
When  we  investigate  the  complexity  of 
the atopic disease than it is easily comprehensible 
that  a  symptomatic  therapy  with  cortisone, 
radiation or antihistamines gives hardly a chance 
for a long term recovery. 
On  the  contrary,  a  functional  concept 
should include a targeted diagnosis of individual 
deviations  in  the  intermediary  metabolism, 
immunological state and nutrition status to offer 
the  appropriate  therapeutically  steps.  The  long 
lasting recovery achieved in more than 80% of all 
cases justifies this integrative therapy concept and 
won  the  acceptance  of  physicians,  patient 
organisations  and  all  health  insurances  who 
integrated the clinic in the official German health 
system. Journal of Medicine and Life  Vol. 2, No.2, April-June 2009  
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